Top Big Data Companies With Best Stability & Growth (2,193)

Strong Revenue Growth: Recent results show year-over-year increases in revenue and test volumes through 2025 and early 2026. Expanding U.S. adoption and rising Galleri volumes are cited as key contributors.

Strategic Partnerships: Announcements include Epic EHR integration to streamline ordering and results across many health systems, supporting broader access. International and channel collaborations, including Samsung-linked expansion plans, are positioned to extend reach.

Investor Backing & Capital Strength: Post–Illumina spin‑off funding and subsequent equity raises point to a multiyear cash runway. Additional financing provides flexibility to pursue regulatory, reimbursement, and commercialization goals.

Strong Revenue Growth: Reported results show six consecutive year-over-year growth quarters, including a 10% increase in the latest reported period, signaling accelerating top-line momentum. Disclosures characterize the upswing as most evident from late 2025 into fiscal 2026.

Strong Market Position & Advantage: Company-cited Comscore figures and trade coverage place the portal firmly as a top-tier, often No. 2 player with rising visit share and leading engagement. This positioning underscores a durable presence even as rivals invest aggressively.

Diversified Revenue Streams: Management attributes gains to premium offerings and expansion into seller, new homes, and rentals, indicating multiple monetization levers beyond core leads. This mix shift supports resilience when unique-user growth is flat.

Strong Revenue Growth: Revenue is accelerating with consistent year-over-year gains and guidance pointing to continued expansion through 2026. Record platform activity and rising deal momentum reinforce top-line trajectory.

Customer Loyalty & Retention: Net dollar retention has improved alongside growth in core genomics customers, indicating expanding usage among existing accounts. Record analyses and repeat adoption across cohorts suggest durable engagement.

Market Expansion: Expansion in the U.S. and APAC and the addition of large integrated health systems support a broader geographic and enterprise footprint. Increasing uptake of newer applications strengthens presence across regions.

Strong Market Position & Advantage: Cleared volumes reached record highs in 2025 and are tracking higher in 2026 while OCC expanded to serve more venues and broadened its product mix. Public updates indicate a wide footprint across equity, ETF, and index options that reinforces competitive advantage.

Resilient & Sustainable Growth: Multi‑year gains in total contracts are accompanied by rising margin and clearing‑fund resources, indicating risk capacity is scaling with activity. Monthly 2026 updates point to continued elevated ADV, supporting durability of the growth trend.

Future-Ready Strategy: OCC is migrating critical market infrastructure to the cloud and investing in multi‑year technology transformation to boost capacity and resiliency. Disclosures indicate these initiatives are designed to handle higher throughput at scale.

Strong Revenue Growth: Multiple signals, including multi‑year FT1000 recognition, recent regional gains, and directionally consistent third‑party revenue scale estimates, indicate sustained expansion. Materials suggest growth continues even if the pace is more measured than earlier years.

Product Line Growth: The launch of a self‑serve platform (rtb.com) and continued moves beyond core enterprise retargeting broaden the offering and expand the addressable market. Evidence points to ongoing product expansion aimed at new customer segments.

Future-Ready Strategy: Active testing and implementation around Chrome’s Privacy Sandbox and participation in industry ecosystems (e.g., Prebid, IAB Tech Lab) show preparation for post‑third‑party‑cookie dynamics. This positioning is presented as a medium‑term growth enabler.

Product Line Growth: Multiple AI-focused capabilities were rolled out across 2024–2026 (e.g., Copilot dashboard, AI Impact measurement, an expanded AI impact suite, and a smarter Jellyfish Assistant), indicating active product investment and roadmap velocity.

Strong Market Position & Advantage: External recognition and reports of a sizable enterprise customer base (e.g., Forbes 2026 Best Startup Employers and 700+ customers cited in local coverage) suggest meaningful traction and credibility.

Investor Backing & Capital Strength: At least $114.5M raised, including a $71M Series C in February 2022, provides capital that underpins continued build-out.

Strong Revenue Growth: Company disclosures describe year-over-year revenue and ARR gains through 2023–2024, highlighted by a record FY2024 and rising capacity under management. Feedback suggests new customer bookings and overall customer count expanded entering 2024 and continued through 2026.

Profitability: The business reported remaining profitable in FY2024 while scaling operations. Feedback suggests this profitability accompanied growth in customers, capacity under management, and deal sizes.

Investor Backing & Capital Strength: A majority/strategic growth investment led by Vista Equity Partners signaled substantial external confidence and scale. Additional backing from firms such as TCV and KKR further supports access to capital for product and go‑to‑market expansion.

Strong Hiring & Retention: Hiring continues at scale across technology, engineering, R&D, and corporate roles, and headcount has risen from a small initial team to well over a thousand within three years. This sustained buildup indicates robust talent acquisition and organizational scaling.

Market Expansion: The Hyderabad GCC expanded its office footprint from 75,000 sq ft to 150,000 sq ft and later to 290,000 sq ft, becoming the company’s largest center outside the United States. This growing physical presence signals continued market expansion and operational reach.

Investor Backing & Capital Strength: A multi‑year India investment commitment of over Rs 1,000 crore and alignment with a financially strong parent provide a stable capital base. Strong parent‑company performance and high ratings underpin ongoing investment capacity for the India operations.

Profitability: Recent reporting cites the company’s first annual profit, signaling improved financial stability after prior flat periods.

Strong Revenue Growth: Independent coverage notes a $125M–$130M annualized revenue run rate by late 2025 into 2026, indicating accelerated top-line momentum.

Market Expansion: Company updates and third-party reports describe expansion into additional states, active hiring, and plans to double the Seattle office footprint to support a larger team.

Strong Revenue Growth: Recent results show revenue increased year over year through 2025 and into Q1 2026, with management raising full‑year 2026 guidance after exceeding the high end of its Q1 outlook. This points to continued momentum if forthcoming quarters meet targets.

Profitability: The company returned to GAAP profitability in 2025 and reported net income again in Q1 2026 alongside strong operating cash generation. Management’s share repurchases further indicate confidence in ongoing earnings and cash flow.

Strategic Partnerships: A long‑term, exclusive Yahoo agreement materially expands distribution, complemented by newer initiatives across Microsoft display inventory and CTV with Paramount and LG. These partnerships broaden reach and demand beyond legacy native placements.

Strategic Partnerships: Recent publisher designations (e.g., Vevo naming DISQO its preferred U.S. brand outcomes measurement partner) and ecosystem integrations point to expanding commercial reach. Additional connections across TV and audio platforms (e.g., DAX US and Comcast Advertising) reinforce partner-led distribution.

Product Line Growth: New launches like AI Search Lift and expanded ACR TV data integrations indicate ongoing investment that broadens measurement capabilities. A free self-serve brand lift offering further extends the product surface to more media companies.

Market Expansion: Partnerships across premium video, audio, and major ad platforms suggest widening channel coverage. Feedback suggests a steady cadence of benchmarks and reports supporting an active go-to-market motion.

Profitability: Company materials indicate it is profitable, bootstrapped, and founder‑owned with a long operating history and meaningful cumulative revenue, providing an internal funding base for continued growth.

Product Line Growth: The March 2026 rebrand from Demand.io to Product.ai with new verification capabilities, a “truth layer for commerce” positioning, and outlined API/Safe Mode plans signals an expanded roadmap and go‑to‑market.

Strong Hiring & Retention: Built In and company profiles show ~25 employees with multiple open roles across functions, indicating active team expansion.

Strong Revenue Growth: Reported results show revenue and subscription ARR rising sharply across FY2026 and into Q1 FY2027. Guidance was raised for FY2027, indicating momentum continuing just after year‑end.

Healthy Cash Flow: Operating and free cash flow turned meaningfully positive with margins improving in recent quarters. Management also points to rising subscription ARR contribution margins, indicating better unit economics as scale increases.

Customer Loyalty & Retention: Large‑customer counts continued to climb and subscription dollar‑based net retention is strong. These trends signal expansion within existing accounts alongside new wins.

Strong Market Position & Advantage: Independent market‑share analysis places the company as the top vendor in a fast‑growing process mining category, indicating outperformance as the market expands. Repeated leader placements in major analyst evaluations reinforce sustained competitive advantage.

Strategic Partnerships: An expanded collaboration with a major hyperscaler (including deeper data integrations) signals stronger routes to market and tighter alignment with enterprise data platforms. Additional alliances across the ecosystem point to broader distribution and solution fit.

Innovation-Driven Growth: Ongoing platform launches oriented to AI and a broader process intelligence roadmap, alongside targeted acquisitions, extend the product’s scope and use cases. Reported customer value realized on the platform indicates innovations are translating into measurable outcomes.

Profitability: Guidance indicates higher Optum operating earnings and margin expansion in 2026 even as revenue right-sizes. Early 2026 updates characterize Optum as contributing to the parent’s overall beat while profitability improves.

Cost & Operational Efficiency: Management is prioritizing mix, pricing, and operational discipline over volume growth following 2025’s challenges. This focus underpins margin expansion despite softer top-line trends.

Diversified Revenue Streams: Pharmacy services grew modestly and Insight was roughly steady while Health contracted, showing multiple engines balancing segment-specific pressures. The 2025 revenue increase was led by Optum Rx with steady gains at Optum Insight.

Strong Revenue Growth: Reported and organic revenue increased in 2025 and accelerated into early 2026, with margins expanding. Q1 2026 showed re‑accelerated momentum supported by multiple engines.

Profitability: Adjusted operating income and margins expanded in 2025 and improved further in Q1 2026. Results show stronger profitability alongside revenue gains.

Diversified Revenue Streams: Multiple businesses—Morningstar Credit, the Morningstar Direct Platform (Data and Direct), PitchBook, and Retirement—drove broad‑based growth. Credit benefited from robust issuance across geographies and asset classes while platforms and data added steady subscription‑led expansion.

Strong Revenue Growth: Recent disclosures point to sharp year-over-year expansion with a multi‑quarter streak of growth into early 2026; feedback suggests momentum remained strong around the IPO timing.

Investor Backing & Capital Strength: An above‑range IPO with significant proceeds and a subsequent credit upgrade indicate healthy investor demand; feedback suggests backing from established sponsors and a 2025 minority investment further reinforce capital flexibility.

Innovation-Driven Growth: Enhancements to its AI platform (Cortex) and launches such as AppRefinery are credited with performance gains and wider adoption; feedback suggests ongoing product velocity supports continued expansion across the app economy.

Profitability: Recent quarters show rising gross profit and expanded non‑GAAP margins, with GAAP profitability achieved in late 2025 and adjusted EBITDA progressing after a solid start to 2026. Feedback suggests operating leverage is improving as the company scales.

Healthy Cash Flow: Free cash flow increased meaningfully in early 2026, and the company reports a sizable cash balance with no debt. These indicators point to improved financial flexibility to support growth and execution.

Product Line Growth: Newer offerings (e.g., Dispute Resolve, ACH risk, broader abuse coverage) are gaining adoption, with more merchants using multiple products. Partnerships and integrations are broadening distribution and reinforcing multi‑product traction.

Profitability: Q1 2026 returned to GAAP profitability with net income of $4.4M versus a loss a year earlier. Adjusted EBITDA grew 16% and the full‑year 2026 margin target was raised to at least 35.5%.

Resilient & Sustainable Growth: Contribution ex‑TAC rose 10% year over year in Q1 2026 and management reaffirmed at least low‑double‑digit ex‑TAC growth for 2026. CTV’s rapid expansion remains the primary engine of the company’s trajectory.

Healthy Cash Flow: Management guided to mid‑30% free‑cash‑flow growth for 2026, signaling improving cash generation alongside margin expansion. This points to operating leverage supporting stronger cash conversion.

Investor Backing & Capital Strength: A $372M Series D in June 2024 led by a16z with Sanofi participation provides substantial capital to expand the pipeline and AI capabilities. Reports characterize this as a material valuation step-up and part of a sizable overall funding base.

Strategic Partnerships: A first-of-its-kind AI collaboration with Sanofi and OpenAI and an out‑licensing deal of gusacitinib to Sanofi (up to €545M) indicate strong external validation and access to enterprise-scale deployment. These alliances reinforce market credibility while opening channels for co-development and monetization.

Product Line Growth: Ongoing in‑licensing (e.g., a CNS‑penetrant TYK2 inhibitor and an anti‑CD226 program) and 2026 updates showing rapid Phase 1 initiation suggest a broadening and advancing portfolio. The rebrand and model shift aim to support a faster-moving, diversified pipeline across immunology and related areas.